ASCA has contacted the FDA to determine whether the statements in the letters are accurate. ASCA asks surgery centers receiving such letters to contact Steve Miller at smiller@ascassociation.org.
Related Articles About ASC Supply Chain:
Precision Spine Receives FDA Clearance for Minimally Invasive Access System
Lutronic Receives FDA Clearance for Phototherapy System
Ethicon Initiates Recall of Select Surgiflo Hemostatic Kits
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.